Adenovirus regulates sumoylation of mre11-Rad50-Nbs1 components through a paralog-specific mechanism

Journal of Virology

Volumn 86, Issue 18, 2012, Pages 9656-9665

  Sohn, Sook Young ^a   Hearing, Patrick ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MRE11 PROTEIN; NIBRIN; RAD50 PROTEIN; UBIQUITIN PROTEIN LIGASE E3; VIRUS DNA;

ADENOVIRUS; ADENOVIRUS INFECTION; ARTICLE; COMPLEX FORMATION; DNA DAMAGE; DNA REPLICATION; NONHUMAN; PARALOGY; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; PROTEIN TRANSPORT; SUMOYLATION; VIRUS INHIBITION; WILD TYPE;

ADENOVIRUS E1B PROTEINS; ADENOVIRUS E4 PROTEINS; ADENOVIRUSES, HUMAN; CELL CYCLE PROTEINS; CELL NUCLEUS; DNA DAMAGE; DNA REPAIR; DNA REPAIR ENZYMES; DNA-BINDING PROTEINS; HELA CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; KINETICS; MUTANT PROTEINS; MUTATION; NUCLEAR PROTEINS; SMALL UBIQUITIN-RELATED MODIFIER PROTEINS; SUMOYLATION;

ADENOVIRIDAE; DNA VIRUSES;

EID: 84866166535     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01273-12     Document Type: Article

References (56)

1. Araujo FD, Stracker TH, Carson CT, Lee DV, Weitzman MD. 2005. Adenovirus type 5 E4orf3 protein targets the Mre11 complex to cytoplasmic aggresomes. J. Virol. 79:11382-11391.
2. Bailey D, O'Hare P. 2004. Characterization of the localization and proteolytic activity of the SUMO-specific protease, SENP1. J. Biol. Chem. 279:692-703.
3. Balakirev MY, Jaquinod M, Haas AL, Chroboczek J. 2002. Deubiquitinating function of adenovirus proteinase. J. Virol. 76:6323-6331.
4. Barker DD, Berk AJ. 1987. Adenovirus proteins from both E1B reading frames are required for transformation of rodent cells by viral infection and DNA transfection. Virology 156:107-121.
5. Bekker-Jensen S, Mailand N. 2011. The ubiquitin- and SUMOdependent signaling response to DNA double-strand breaks. FEBS Lett. 585:2914-2919.
6. Bentz GL, Whitehurst CB, Pagano JS. 2011. Epstein-Barr virus latent membrane protein 1 (LMP1) C-terminal-activating region 3 contributes to LMP1-mediated cellular migration via its interaction with Ubc9. J. Virol. 85:10144-10153.
7. Bischof O, et al. 2006. The E3 SUMO ligase PIASy is a regulator of cellular senescence and apoptosis. Mol. Cell 22:783-794.
8. Boggio R, Colombo R, Hay RT, Draetta GF, Chiocca S. 2004. A mechanism for inhibiting the SUMO pathway. Mol. Cell 16:549-561.
9. Boutell C, et al. 2011. A viral ubiquitin ligase has substrate preferential SUMO targeted ubiquitin ligase activity that counteracts intrinsic antiviral defence. PLoS Pathog. 7:e1002245. doi:10.1371/journal.ppat.1002245.
10. Carson CT, et al. 2009. Mislocalization of the MRN complex prevents ATR signaling during adenovirus infection. EMBO J. 28:652-662.
11. Carvalho T, et al. 1995. Targeting of adenovirus E1A and E4-ORF3 proteins to nuclear matrix-associated PML bodies. J. Cell Biol. 131:45-56.
12. Chang PC, et al. 2010. Kaposi's sarcoma-associated herpesvirus (KSHV) encodes a SUMO E3 ligase that is SIM-dependent and SUMO-2/3-specific. J. Biol. Chem. 285:5266-5273.
13. Cremona CA, et al. 2012. Extensive DNA damage-induced sumoylation contributes to replication and repair and acts in addition to the mec1 checkpoint. Mol. Cell 45:422-432.
14. Cutt J, Shenk T, Hearing P. 1987. Analysis of adenovirus early region 4-encoded polypeptides synthesized in productively infected cells. J. Virol. 61:543-552.
15. Dou H, Huang C, Van Nguyen T, Lu LS, Yeh ET. 2011. SUMOylation and de-SUMOylation in response to DNA damage. FEBS Lett. 585:2891-2896.
16. Doucas V, et al. 1996. Adenovirus replication is coupled with the dynamic properties of the PML nuclear structure. Genes Dev. 10:196-207.
17. Endter C, Kzhyshkowska J, Stauber R, Dobner T. 2001. SUMO-1 modification required for transformation by adenovirus type 5 early region 1B 55-kDa oncoprotein. Proc. Natl. Acad. Sci. U. S. A. 98:11312-11317.
18. Evans JD, Hearing P. 2003. Distinct roles of the adenovirus E4 ORF3 protein in viral DNA replication and inhibition of genome concatenation. J. Virol. 77:5295-5304.
19. Evans JD, Hearing P. 2005. Relocalization of the Mre11-Rad50-Nbs1 complex by the adenovirus E4 ORF3 protein is required for viral replication. J. Virol. 79:6207-6215.
20. Fox JT, Lee KY, Myung K. 2011. Dynamic regulation of PCNA ubiquitylation/deubiquitylation. FEBS Lett. 585:2780-2785.
21. Galanty Y, et al. 2009. Mammalian SUMO E3-ligases PIAS1 and PIAS4 promote responses to DNA double-strand breaks. Nature 462:935-939.
22. Gareau JR, Lima CD. 2010. The SUMO pathway: emerging mechanisms that shape specificity, conjugation and recognition. Nat. Rev. Mol. Cell Biol. 11:861-871.
23. Goodrum FD, Ornelles DA. 1999. Roles for the E4 orf6, orf3, and E1B 55-kilodalton proteins in cell cycle-independent adenovirus replication. J. Virol. 73:7474-7488.
24. Harada JN, Shevchenko A, Pallas DC, Berk AJ. 2002. Analysis of the adenovirus E1B-55K-anchored proteome reveals its link to ubiquitination machinery. J. Virol. 76:9194-9206.
25. Huang M, Hearing P. 1989. Adenovirus early region 4 encodes two gene products with redundant effects in lytic infection. J. Virol. 63:2605-2615.
26. Hwang J, Kalejta RF. 2009. Human cytomegalovirus protein pp71 induces Daxx SUMOylation. J. Virol. 83:6591-6598.
27. Jones N, Shenk T. 1979. Isolation of adenovirus type 5 host range deletion mutants defective for transformation of rat embryo cells. Cell 17:683-689.
28. Karen KA, Hearing P. 2011. Adenovirus core protein VII protects the viral genome from a DNA damage response at early times after infection. J. Virol. 85:4135-4142.
29. Karen KA, Hoey PJ, Young C, Hearing P. 2009. Temporal regulation of the Mre11-Rad50-Nbs1 complex during adenovirus infection. J. Virol. 83:4565-4573.
30. Kindsmüller K, et al. 2007. Intranuclear targeting and nuclear export of the adenovirus E1B-55K protein are regulated by SUMO1 conjugation. Proc. Natl. Acad. Sci. U. S. A. 104:6684-6689.
31. Lamarche BJ, Orazio NI, Weitzman MD. 2010. The MRN complex in double-strand break repair and telomere maintenance. FEBS Lett. 584:3682-3695.
32. Ledl A, Schmidt D, Müller S. 2005. Viral oncoproteins E1A and E7 and cellular LxCxE proteins repress SUMO modification of the retinoblastoma tumor suppressor. Oncogene 24:3810-3818.
33. Liu Y, Shevchenko A, Berk AJ. 2005. Adenovirus exploits the cellular aggresome response to accelerate inactivation of the MRN complex. J. Virol. 79:14004-14016.
34. Marcos-Villar L, et al. 2011. Covalent modification by SUMO is required for efficient disruption of PML oncogenic domains by Kaposi's sarcomaassociated herpesvirus latent protein LANA2. J. Gen. Virol. 92:188-194.
35. Morris JR, et al. 2009. The SUMO modification pathway is involved in the BRCA1 response to genotoxic stress. Nature 462:886-890.
36. Mukhopadhyay D, Dasso M. 2007. Modification in reverse: the SUMO proteases. Trends Biochem. Sci. 32:286-295.
37. Muller S, Dobner T. 2008. The adenovirus E1B-55K oncoprotein induces SUMO modification of p53. Cell Cycle 7:754-758.
38. Nordqvist K, Ohman K, Akusjarvi G. 1994. Human adenovirus encodes two proteins which have opposite effects on accumulation of alternatively spliced mRNAs. Mol. Cell. Biol. 14:437-445.
39. Pennella MA, Liu Y, Woo JL, Kim CA, Berk AJ. 2010. Adenovirus E1B 55-kilodalton protein is a p53-SUMO1 E3 ligase that represses p53 and stimulates its nuclear export through interactions with promyelocytic leukemia nuclear bodies. J. Virol. 84:12210-12225.
40. Pichler A, Melchior F. 2002. Ubiquitin-related modifier SUMO1 and nucleocytoplasmic transport. Traffic 3:381-387.
41. Pilder S, Moore M, Logan J, Shenk T. 1986. The adenovirus E1B-55K transforming polypeptide modulates transport or cytoplasmic stabilization of viral and host cell mRNAs. Mol. Cell. Biol. 6:470-476.
42. Querido E, et al. 2001. Degradation of p53 by adenovirus E4orf6 and E1B55K proteins occurs via a novel mechanism involving a Cullincontaining complex. Genes Dev. 15:3104-3117.
43. Shepard RN, Ornelles DA. 2004. Diverse roles for E4orf3 at late times of infection revealed in an E1B 55-kilodalton protein mutant background. J. Virol. 78:9924-9935.
44. Shepard RN, Ornelles DA. 2003. E4orf3 is necessary for enhanced Sphase replication of cell cycle-restricted subgroupCadenoviruses. J. Virol. 77:8593-8595.
45. Sohn SY, Hearing P. 2011. Adenovirus sequesters phosphorylated STAT1 at viral replication centers and inhibits STAT dephosphorylation. J. Virol. 85:7555-7562.
46. Soria C, Estermann FE, Espantman KC, O'Shea CC. 2010. Heterochromatin silencing of p53 target genes by a small viral protein. Nature 466: 1076-1081.
47. Stracker TH, Carson CT, Weitzman MD. 2002. Adenovirus oncoproteins inactivate the Mre11-Rad50-NBS1 DNA repair complex. Nature 418:348-352.
48. Stracker TH, et al. 2005. Serotype-specific reorganization of the Mre11 complex by adenoviral E4orf3 proteins. J. Virol. 79:6664-6673.
49. Tatham MH, Rodriguez MS, Xirodimas DP, Hay RT. 2009. Detection of protein SUMOylation in vivo. Nat. Protoc. 4:1363-1371.
50. Wang YE, Pernet O, Lee B. 2012. Regulation of the nucleocytoplasmic trafficking of viral and cellular proteins by ubiquitin and small ubiquitinrelated modifiers. Biol. Cell 104:121-138.
51. Weitzman MD, Ornelles DA. 2005. Inactivating intracellular antiviral responses during adenovirus infection. Oncogene 24:7686-7696.
52. Wilson VG. 2012. Sumoylation at the host-pathogen interface. Biomolecules 2:203-227.
53. Wimmer P, Schreiner S, Dobner T. 2012. Human pathogens and the host cell SUMOylation system. J. Virol. 86:642-654.
54. Wimmer P, et al. 2010. SUMO modification of E1B-55K oncoprotein regulates isoform-specific binding to the tumour suppressor protein PML. Oncogene 29:5511-5522.
55. Yew PR, Cheng Kao C, Berk AJ. 1990. Dissection of functional domains in the adenovirus 2 early 1B 55K polypeptide by suppressor-linker insertional mutagenesis. Virology 179:795-805.
56. Yousef A, et al. 2010. Identification of a molecular recognition feature in the E1A oncoprotein that binds the SUMO conjugase UBC9 and likely interferes with polySUMOylation. Oncogene 29:4693-4704.